article thumbnail

FDA reviewers back Pfizer/BioNTech COVID-19 vaccine ahead of panel

pharmaphorum

The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go. But there are still unanswered questions that can only be addressed once the shot is administered to the wider public. of participants.

Vaccines 111
article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

The integration of real-time track and trace technology, handheld mobile smart devices and advanced analytics solutions into the COVID-19 vaccine rollout is our best shot to enhance the global vaccination effort and combat new variants with herd immunity. Adverse reactions to the vaccine. Critical supply chain visibility.

Vaccines 119